232 related articles for article (PubMed ID: 22176921)
1. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis.
Fogelstrand P; Borén J
Nutr Metab Cardiovasc Dis; 2012 Jan; 22(1):1-7. PubMed ID: 22176921
[TBL] [Abstract][Full Text] [Related]
2. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
[TBL] [Abstract][Full Text] [Related]
3. Role of extracellular retention of low density lipoproteins in atherosclerosis.
Borén J; Gustafsson M; Skålén K; Flood C; Innerarity TL
Curr Opin Lipidol; 2000 Oct; 11(5):451-6. PubMed ID: 11048887
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis.
Olofsson SO; Borèn J
J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of lipoprotein retention by the extracellular matrix.
Gustafsson M; Borén J
Curr Opin Lipidol; 2004 Oct; 15(5):505-14. PubMed ID: 15361785
[TBL] [Abstract][Full Text] [Related]
6. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
[TBL] [Abstract][Full Text] [Related]
7. Interaction of native and modified low-density lipoproteins with extracellular matrix.
Chait A; Wight TN
Curr Opin Lipidol; 2000 Oct; 11(5):457-63. PubMed ID: 11048888
[TBL] [Abstract][Full Text] [Related]
8. [Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].
Hurt-Camejo E; Camejo G
Invest Clin; 2001 May; 42 Suppl 1():43-73. PubMed ID: 11416984
[TBL] [Abstract][Full Text] [Related]
9. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
[TBL] [Abstract][Full Text] [Related]
10. Hyperelongated biglycan: the surreptitious initiator of atherosclerosis.
Little PJ; Osman N; O'Brien KD
Curr Opin Lipidol; 2008 Oct; 19(5):448-54. PubMed ID: 18769225
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.
de Dios ST; Frontanilla KV; Nigro J; Ballinger ML; Ivey ME; Cawson EA; Little PJ
J Diabetes Complications; 2007; 21(2):108-17. PubMed ID: 17331859
[TBL] [Abstract][Full Text] [Related]
12. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake.
Kaplan M; Aviram M
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):386-93. PubMed ID: 11231918
[TBL] [Abstract][Full Text] [Related]
13. Glycosaminoglycans as key molecules in atherosclerosis: the role of versican and hyaluronan.
Karangelis DE; Kanakis I; Asimakopoulou AP; Karousou E; Passi A; Theocharis AD; Triposkiadis F; Tsilimingas NB; Karamanos NK
Curr Med Chem; 2010; 17(33):4018-26. PubMed ID: 20939824
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
Wilson PG; Thompson JC; Webb NR; de Beer FC; King VL; Tannock LR
Am J Pathol; 2008 Dec; 173(6):1902-10. PubMed ID: 18974302
[TBL] [Abstract][Full Text] [Related]
15. Arterial wall injury and proteoglycan changes in atherosclerosis.
Berenson GS; Radhakrishnamurthy B; Srinivasan SR; Vijayagopal P; Dalferes ER
Arch Pathol Lab Med; 1988 Oct; 112(10):1002-10. PubMed ID: 3052350
[TBL] [Abstract][Full Text] [Related]
16. Induction of anti-anti-idiotype antibodies against sulfated glycosaminoglycans reduces atherosclerosis in apolipoprotein E-deficient mice.
Brito V; Mellal K; Portelance SG; Pérez A; Soto Y; deBlois D; Ong H; Marleau S; Vázquez AM
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2847-54. PubMed ID: 23087361
[TBL] [Abstract][Full Text] [Related]
17. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
Tabas I; Williams KJ; Borén J
Circulation; 2007 Oct; 116(16):1832-44. PubMed ID: 17938300
[TBL] [Abstract][Full Text] [Related]
18. Dietary alterations of plasma lipoproteins influence their interactions with proteoglycan enriched extracts from neointima of normal and injured aorta of rabbit.
Alavi MZ; Galis Z; Li ZH; Moore S
Clin Invest Med; 1991 Oct; 14(5):419-31. PubMed ID: 1742920
[TBL] [Abstract][Full Text] [Related]
19. Oxidized LDL binding to a macrophage-secreted extracellular matrix.
Kaplan M; Aviram M
Biochem Biophys Res Commun; 1997 Aug; 237(2):271-6. PubMed ID: 9268699
[TBL] [Abstract][Full Text] [Related]
20. Identification of the proteoglycan binding site in apolipoprotein B48.
Flood C; Gustafsson M; Richardson PE; Harvey SC; Segrest JP; Borén J
J Biol Chem; 2002 Aug; 277(35):32228-33. PubMed ID: 12070165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
